Study reveals potential cognitive benefits of antidiabetic drugs

FHS
July 12, 2024
5:05 pm

Investigators analyzing the potential cognitive effects of antidiabetic medications in records of more than 1.5 million patients with type 2 diabetes mellitus (T2DM) found risks of dementia and Alzheimer’s disease (AD) were significantly lower in patients treated with metformin and sodium glucose co-transporter-2 inhibitors (SGLT-2i) compared to other antidiabetic drugs.

Fold Health Lands $6M for Optimization Platform for Primary Care

What You Should Know: – Fold Health,a San Francisco, CA-based platform supporting value-based primary care raises $6M in funding from Iron Pillar and global angel

July 13, 2023

Exploring molecular mechanisms and genetic dysregulation in aging and age-associated diseases

Researchers review existing data on the molecular basis of senescence and neurodegeneration in age-related brain diseases.

August 10, 2023

Novel framework enhances MRI segmentation using unlabeled data

Researchers from Peking University Third Hospital have developed a novel collaborative framework that integrates various semi-supervised learning techniques to enhance MRI segmentation using unlabeled data.

October 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.